Mon–Fri, 8:00 AM–6:00 PM, ET
Learn more »
For referring physicians »
News and Insights from Memorial Sloan-Kettering See all blog posts »
A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
When a test showed two dark spots on his chest, Ali Hanna assumed his ocular melanoma had recurred. He was stunned to learn he had pleural mesothelioma.
The grant, which Dr. Hasan will use to develop novel immune therapies for two childhood cancers, was presented at Memorial Sloan-Kettering and involved a special activity for pediatric patients.
Dr. Strong, a minimally invasive surgery specialist, talks about walking her patients through the steps of the treatment process to ease any concerns before a procedure.
Memorial Sloan-Kettering Cancer Center has learned of a security breach that may have resulted in exposure of protected health information (PHI) of some our patients.
Learn more »
You may have access to new experimental treatments by participating in a clinical trial.
Inpatient Hospital & Main Campus »
New York City Outpatient Facilities »
Suburban Outpatient Treatment Centers »
Research Facilities »
Find the latest press releases, media guidelines, and Memorial Sloan-Kettering facts and figures.
Enter Pressroom »
Contact Media Staff »
The fulfillment of our mission depends on your support.
Explore ways to give »